Related Experiment Video
Updated: Jul 10, 2026

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
Published on: September 25, 2016
Blood RNA Biomarker Signatures for Early Diagnosis and Prognosis in Ischemic and Hemorrhagic Stroke: The IBIS-CT1
Salomé Retailleau1, Marie Bruguet2, Irina Viakhireva-Dovganyuk2
1Univ Brest, Inserm, EFS, UMR 1078, GGB, Brest, France.
Objective:
To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication.
Methods:
IBIS-CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH) within 6 h of onset, compared with healthy controls (HC). Blood samples were collected at < 6 h (early), 12 h, 24 h, 48 h, 7 days, and 3 months. Target RNAs were quantified using reverse-transcription PCR or digital droplet PCR. Clinical severity and disability were assessed by NIHSS at admission and the modified Rankin Scale (mRS) at 3 months.
Results:
Twenty HC, 20 IS, and 20 ICH patients were included. Compared with HC, IS patients showed significant early upregulation of genes ADM, DUSP1, HMOX1, HSPA1B, LDLR, and PTGS2 (all p ≤ 0.0002) and downregulation of BAG3 (p < 0.0001). Similar patterns were observed in ICH, with higher expression levels than in IS. In IS, higher NIHSS scores correlated with early upregulation of ADM, DUSP1, HMOX1, PTGS2, and GOS2, while lower BAG3 expression associated with poorer 3-month outcomes. Combined gene expression discriminated stroke from controls with an AUC of 0.914 (95% CI, 0.84-0.98).
Interpretation:
Distinct blood gene-expression signatures differentiate stroke from controls and predict functional outcome, supporting their potential as diagnostic and prognostic biomarkers.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Ischemic Stroke l: Introduction